Atrial angiosarcoma imaged by F-18 FDG PET/CT

18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature

“…Scattered case reports in literature describe how integrated PET/CT with FDG imaging can incidentally show cardiac neoplasia, particularly metastatic involvement, 11 – 17 or may be used in case of suspected aggressive cardiac malignancy to strengthen the diagnosis and detect possible occult distant disease. 18 – 26 …”

Metabolic activity assessment of cardiac angiosarcoma by 18FDG PET-CT

“…They are proving its usefulness in assessing malignant potential of the tumour mass and exploration for distant metastases in primary diagnosis together with metabolic response to and detection of local recurrence after applied therapy [5][6][7][8]. In the presented case PET-CT with 18FDG depicted persisted high metabolic activity in the tumour mass despite three courses of adjuvant chemotherapy and metabolically active metastases in the skeleton, not visible on previously scheduled imaging studies.…”

18F-FDG PET-CT for Evaluation of Cardiac Angiosarcoma: A Case Report and Review of Literature

“…18F-FDG PET-CT has been evaluated for characterisation, staging and restaging of cardiac angiosarcomas. A brief review of literature in this regard is presented in Table ( 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 ). Rahbar et al in their study on 24 patients with cardiac tumors (including 6 angiosarcomas) concluded that with a cut-off SUVmax of 3.5, 18F-FDG PET-CT could be used to noninvasively determine malignant tumors with a sensitivity of 100% ( 22 ).…”